Biologic-assisted house dust mite immunotherapy in allergic asthma: could it provide a bridge toward de-escalation?
0 citations
Abstract
To the Editor,We read with great interest the three-year randomized study by Bozek and colleagues comparing omalizumab, subcutaneous house dust mite allergen immunotherapy (HDM-SCIT), their combina...
// Source
Authors: Simon Høj, Howraman Meteran
Institutions: University of Copenhagen, Rigshospitalet, Aarhus University, Hvidovre Hospital